I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| kidney loop of Henle epithelial cell | 6 studies | 20% ± 3% | |
| plasmablast | 5 studies | 35% ± 17% | |
| epithelial cell | 5 studies | 42% ± 17% | |
| CD8-positive, alpha-beta T cell | 5 studies | 22% ± 5% | |
| hematopoietic precursor cell | 4 studies | 26% ± 10% | |
| CD4-positive, alpha-beta T cell | 4 studies | 23% ± 8% | |
| erythroblast | 4 studies | 41% ± 16% | |
| endothelial cell | 4 studies | 26% ± 7% | |
| ciliated cell | 4 studies | 35% ± 6% | |
| pancreatic A cell | 3 studies | 24% ± 4% | |
| conventional dendritic cell | 3 studies | 36% ± 13% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 23% ± 3% | |
| erythrocyte | 3 studies | 33% ± 12% | |
| B cell | 3 studies | 21% ± 4% | |
| dendritic cell | 3 studies | 33% ± 16% | |
| intestinal crypt stem cell | 3 studies | 20% ± 4% | |
| basal cell | 3 studies | 33% ± 12% | |
| natural killer cell | 3 studies | 23% ± 5% |
